Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Other Working Capital Changes (2016 - 2026)

Eledon Pharmaceuticals filings provide 5 years of Other Working Capital Changes readings, the most recent being -$244000.0 for Q4 2017.

  • On a quarterly basis, Other Working Capital Changes fell 960.87% to -$244000.0 in Q4 2017 year-over-year; TTM through Dec 2017 was $517000.0, a 895.38% increase, with the full-year FY2025 number at -$1.2 million, up 4.39% from a year prior.
  • Other Working Capital Changes hit -$244000.0 in Q4 2017 for Eledon Pharmaceuticals, up from -$406000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.5 million in Q3 2015 to a low of -$549000.0 in Q4 2015.
  • Median Other Working Capital Changes over the past 5 years was $3000.0 (2016), compared with a mean of $191176.5.
  • Biggest five-year swings in Other Working Capital Changes: soared 9850.0% in 2014 and later tumbled 13633.33% in 2017.
  • Eledon Pharmaceuticals' Other Working Capital Changes stood at $10000.0 in 2013, then soared by 9850.0% to $995000.0 in 2014, then plummeted by 155.18% to -$549000.0 in 2015, then skyrocketed by 95.81% to -$23000.0 in 2016, then tumbled by 960.87% to -$244000.0 in 2017.
  • The last three reported values for Other Working Capital Changes were -$244000.0 (Q4 2017), -$406000.0 (Q3 2017), and $1.2 million (Q2 2017) per Business Quant data.